Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Neuroxelin Dosage Protocol | PeptideDosages.com

Neuroxelin (48 mg Vial) Dosage Protocol Neuroxelin Dosage Chart The Neuroxelin peptide blend is dosed at 500 mcg–750 mcg daily via subcutaneous injection in educational protocols. A 48 mg vial reconstituted with bacteriostatic water yields about 16 mg/mL. This

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Neuroxelin (48 mg Vial) Dosage Protocol

Neuroxelin Dosage Chart

The Neuroxelin peptide blend is dosed at 500 mcg–750 mcg daily via subcutaneous injection in educational protocols. A 48 mg vial reconstituted with bacteriostatic water yields about 16 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → 16 mg/mL concentration.

Typical daily range: 250–1000 mcg once daily (standard dose: 500 mcg).

Easy measuring: At 16 mg/mL, 1 unit = 0.01 mL = 160 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Neuroxelin dosage protocols are designed to support neuroprotection and cognitive recovery following brain injury or stroke. As a synthetic neuroprotective peptide, Neuroxelin may help reduce excitotoxic damage, modulate neuroinflammation, and support neural repair processes[1][2]. Research suggests that Neuroxelin-class peptides can promote improved neurological outcomes and cognitive function when administered consistently over several weeks[3][4]. This educational protocol outlines a once-daily subcutaneous approach optimized for sustained neuroprotective coverage.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read What Is Neuroxelin? An Evidence-Based Guide to the Peptide Blend.

Standard / Gradual Approach (3 mL = 16 mg/mL)

Weeks 1–4

500 mcg

3 units (0.03 mL)

Weeks 5–8

750 mcg

4.7 units (0.047 mL)

Frequency: Inject once daily subcutaneously, preferably in the morning. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Alternative Dosing Tiers

Conservative

250 mcg

1.6 units (0.016 mL)

Typical

3.1 units (0.031 mL)

Aggressive

1000 mcg

6.3 units (0.063 mL)

Reconstitution Steps

Allow lyophilized vial to reach room temperature before opening.

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label with concentration (16 mg/mL) and date; refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–12 week daily protocol at the typical 500 mcg dose.

Peptide Vials (Neuroxelin, 48 mg each):

8 weeks (500 mcg/day): 1 vial (28 mg used; ~58% of vial)

12 weeks (500 mcg/day): 1 vial (42 mg used; ~88% of vial)

8 weeks (1000 mcg/day): 2 vials (56 mg needed)

Insulin Syringes (U-100, 30- or 50-unit recommended):

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

1 vial reconstitution: 3 mL → 1 × 10 mL bottle

2 vials reconstitution: 6 mL → 1 × 10 mL bottle

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Neuroxelin vs “similar blends”

Many “focus/calm/nootropic” peptide blends are variations on the same concept: combine one “focus” peptide with one “calm” peptide, sometimes adding a resilience/aging peptide and/or an ion…

Source: peptidedosages.com
Research context

Read sources and limitations before applying a claim.

Additional Research and Background

These sources provide related context and are not presented as support for a specific statement above. Subcutaneous Drug Injection Review / PMC — Pharmacologic considerations of the subcutaneous route View Source Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable. Research overview BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research TB-500 Peptide: Benefits, Uses, Side Effects, Dosage, and Research KPV Peptide: Benefits, Uses, Side Effects, Dosage, and Research Related protocols and comparisons BPC-157 (5 mg Vial) Dosage Protocol BPC-157 (10 mg Vial) Dosage Protocol BPC-157 + TB-500 (10 mg Blend) Dosage Protocol BPC-157 + TB-500 (20 mg Blend) Dosage Protocol TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol GLOW (70 mg Blend) Dosage Protocol KLOW (80 mg Blend) Dosage Protocol TB-500 (5 mg Vial) Dosage Protocol Practical guides Peptide Blend Dosages Peptide Dosage & Reconstitution Calculator How to Reconstitute Peptides Syringe & Measurement Guide Peptide Storage Guide Peptide Dosage Chart

Source: peptidedosages.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →